CytomX Therapeutics Announces Details of Presentations at the American Society of Clinical Oncology ASCO20 Virtual Scientific Program

NEXT STORY
Galera Therapeutics Announces New Data from the Phase 2b Trial on the Effect of Avasopasem Manganese on Cisplatin-Induced Chronic Kidney Disease to be Presented at ASCO 2020 Virtual Scientific Program
PREV STORY
SEngine Precision Medicine to Present Data Related to the Predictive Value of the PARIS® Test for Oncology Drugs Based on Retrospective Analysis at 2020 ASCO Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea

author_avatar
NASDAQ Market News

Cassava Sciences Announces Full-year 2019 Financial Results and Anticipated Key Milestones for 2020

author_avatar
NASDAQ Market News

Apricus Biosciences Provides Corporate Update and First Quarter Financial Results

SAN DIEGO, May 09, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

author_avatar
NASDAQ Market News